» Articles » PMID: 20558236

The Nociceptive and Anti-nociceptive Effects of Bee Venom Injection and Therapy: a Double-edged Sword

Overview
Journal Prog Neurobiol
Specialty Neurology
Date 2010 Jun 19
PMID 20558236
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Bee venom injection as a therapy, like many other complementary and alternative medicine approaches, has been used for thousands of years to attempt to alleviate a range of diseases including arthritis. More recently, additional theraupeutic goals have been added to the list of diseases making this a critical time to evaluate the evidence for the beneficial and adverse effects of bee venom injection. Although reports of pain reduction (analgesic and antinociceptive) and anti-inflammatory effects of bee venom injection are accumulating in the literature, it is common knowledge that bee venom stings are painful and produce inflammation. In addition, a significant number of studies have been performed in the past decade highlighting that injection of bee venom and components of bee venom produce significant signs of pain or nociception, inflammation and many effects at multiple levels of immediate, acute and prolonged pain processes. This report reviews the extensive new data regarding the deleterious effects of bee venom injection in people and animals, our current understanding of the responsible underlying mechanisms and critical venom components, and provides a critical evaluation of reports of the beneficial effects of bee venom injection in people and animals and the proposed underlying mechanisms. Although further studies are required to make firm conclusions, therapeutic bee venom injection may be beneficial for some patients, but may also be harmful. This report highlights key patterns of results, critical shortcomings, and essential areas requiring further study.

Citing Articles

Antimicrobial Properties of Hive Products and Their Potential Applications in Human and Veterinary Medicine.

Bava R, Puteo C, Lombardi R, Garcea G, Lupia C, Spano A Antibiotics (Basel). 2025; 14(2).

PMID: 40001416 PMC: 11851452. DOI: 10.3390/antibiotics14020172.


Activation of mouse skin mast cells and cutaneous afferent C-fiber subtypes by bee venom.

Jurcakova D, Ru F, Pecova R, Undem B Neurosci Lett. 2024; 845:138061.

PMID: 39603444 PMC: 11780664. DOI: 10.1016/j.neulet.2024.138061.


Bee products: An overview of sources, biological activities and advanced approaches used in apitherapy application.

El-Didamony S, Gouda H, Zidan M, Amer R Biotechnol Rep (Amst). 2024; 44:e00862.

PMID: 39507381 PMC: 11538619. DOI: 10.1016/j.btre.2024.e00862.


Bee-Inspired Healing: Apitherapy in Veterinary Medicine for Maintenance and Improvement Animal Health and Well-Being.

Stevanovic J, Glavinic U, Ristanic M, Erjavec V, Denk B, Dolasevic S Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204155 PMC: 11357515. DOI: 10.3390/ph17081050.


Antioxidant Activity and Mechanism of Action of Amwaprin: A Protein in Honeybee () Venom.

Kim B, Lee K, Jin B Antioxidants (Basel). 2024; 13(4).

PMID: 38671917 PMC: 11047345. DOI: 10.3390/antiox13040469.


References
1.
Baumann T, Simone D, Shain C, LaMotte R . Neurogenic hyperalgesia: the search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia. J Neurophysiol. 1991; 66(1):212-27. DOI: 10.1152/jn.1991.66.1.212. View

2.
Nam K, Je K, Lee J, Han H, Lee H, Kang S . Inhibition of COX-2 activity and proinflammatory cytokines (TNF-alpha and IL-1beta) production by water-soluble sub-fractionated parts from bee (Apis mellifera) venom. Arch Pharm Res. 2003; 26(5):383-8. DOI: 10.1007/BF02976695. View

3.
Bechinger B . Structure and functions of channel-forming peptides: magainins, cecropins, melittin and alamethicin. J Membr Biol. 1997; 156(3):197-211. DOI: 10.1007/s002329900201. View

4.
BANKS B, Dempsey C, Vernon C, Warner J, Yamey J . Anti-inflammatory activity of bee venom peptide 401 (mast cell degranulating peptide) and compound 48/80 results from mast cell degranulation in vivo. Br J Pharmacol. 1990; 99(2):350-4. PMC: 1917405. DOI: 10.1111/j.1476-5381.1990.tb14707.x. View

5.
Dickenson A, Haley J, Schachter M, Chapman V . Electrophysiological approaches to the study of bradykinin and nitric oxide in inflammatory pain. Agents Actions Suppl. 1992; 38 ( Pt 2):358-65. View